Csilla Krausz


Csilla Krausz obtained her MD in 1990 and her specialization in Endocrinology and Metabolic Diseases in 1995 at the University of Florence, Italy; and her PhD in Human Genetics in 2001 at the Pasteur Institute/University Paris 7, France. Currently she is Professor in Endocrinology and research group leader at the University of Florence, Italy and co-director of the Florence European Academy of Andrology (EAA) Training Center in Andrology. Her first research field was spermatology with special interest in oxidative stress and functional sperm parameters. Starting from 1995 she is focusing on genetics and epigenetics of male infertility, hypogonadism, cryptorchidism, testis tumor and genomic instability of the male gamete. Her major scientific achievements concern the X and Y chromosome-linked CNVs (deletions) and their clinical significance. She is author of more than 140 scientific publications in international peer-reviewed journals and her H citation index is 43. According to a recent worldwide survey, she is among the top 20 most productive authors on male infertility research from 1995. She is an Academician of the European Academy of Andrology (EAA) and in 2014 has been elected as the President of the EAA for the period 2014- 2018. In 2017 has been appointed by the ESE as the Clinical Lead of the Reproductive Endocrinology focus area.

The Latest

News & Events

Breaking Ground in Cancer Research: Introducing the Fanconi Cancer Foundation-AACR NextGen Grant

That's why we're thrilled to announce the launch of the Fanconi Cancer Foundation-AACR NextGen Grant for Transformative Cancer Research, a flagship funding opportunity in partnership with the American Association for Cancer Research (AACR).

Read More >

Introducing the Fanconi Cancer Foundation: A New Era in FA Research & Impact

In 1989, Lynn and David Frohnmayer founded the Fanconi Anemia Research Fund (FARF), determined and desperate to find a cure for their three daughters diagnosed with Fanconi anemia (FA). Since then, their vision has grown into a vibrant community of FA families, researchers, clinicians, donors, fundraisers, staff, and volunteers, all dedicated to improving outcomes for people with FA.

Read More >
DNA strands

2024 Research Updates

Research is the answer to one day making FA a treatable, manageable disease. Here, you'll discover the most recent strides in FA research and activities funded by FCF. Every quarter, we'll bring you updates on newly funded grants, ongoing projects, and significant milestones.

Read More >